Eli Lilly & Co. (LLY)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 7 |
| Ownership rank: | 49 |
| % of all portfolios: | 0.194% |
| Hold Price * : | $772.00 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
99 |
$2,386,324,137 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Stephen Mandel - Lone Pine Capital |
4.49 |
Buy |
782,860 |
604,368,000 |
| ≡ |
Chase Coleman - Tiger Global Management |
3.82 |
Add 35.08% |
1,309,960 |
1,011,289,000 |
| ≡ |
Polen Capital Management |
2.70 |
Add 164.39% |
1,295,389 |
1,000,040,000 |
| ≡ |
John Armitage - Egerton Capital |
2.51 |
Buy |
280,981 |
216,917,000 |
| ≡ |
Mairs & Power Growth Fund |
1.76 |
|
124,539 |
96,144,000 |
| ≡ |
Torray Funds |
0.04 |
|
398 |
307,000 |
| ≡ |
David Katz - Matrix Asset Advisors |
0.03 |
|
302 |
233,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock